This report aims to provide a comprehensive presentation of the global market for Highly Active Antiretroviral Therapy (HAART), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Highly Active Antiretroviral Therapy (HAART). This report contains market size and forecasts of Highly Active Antiretroviral Therapy (HAART) in global, including the following market information:
Global Highly Active Antiretroviral Therapy (HAART) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Highly Active Antiretroviral Therapy (HAART) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Nucleoside Reverse Transcriptase Inhibitors (NRTI) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Highly Active Antiretroviral Therapy (HAART) include Gilead, Roche, ViiV Healthcare, Boehringer Ingelheim, Johnson and Johnson, Mylan, Bionor Pharma, Vertex Pharmaceuticals and Merck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Highly Active Antiretroviral Therapy (HAART) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Highly Active Antiretroviral Therapy (HAART) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Highly Active Antiretroviral Therapy (HAART) Market Segment Percentages, by Type, 2022 (%)
Nucleoside Reverse Transcriptase Inhibitors (NRTI)
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Protease Inhibitor (PI)
Global Highly Active Antiretroviral Therapy (HAART) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Highly Active Antiretroviral Therapy (HAART) Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Highly Active Antiretroviral Therapy (HAART) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Highly Active Antiretroviral Therapy (HAART) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Highly Active Antiretroviral Therapy (HAART) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Highly Active Antiretroviral Therapy (HAART) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead
Roche
ViiV Healthcare
Boehringer Ingelheim
Johnson and Johnson
Mylan
Bionor Pharma
Vertex Pharmaceuticals
Merck
CIPLA
AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Highly Active Antiretroviral Therapy (HAART), market overview.
Chapter 2: Global Highly Active Antiretroviral Therapy (HAART) market size in revenue.
Chapter 3: Detailed analysis of Highly Active Antiretroviral Therapy (HAART) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Highly Active Antiretroviral Therapy (HAART) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Highly Active Antiretroviral Therapy (HAART) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Highly Active Antiretroviral Therapy (HAART) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Highly Active Antiretroviral Therapy (HAART) Overall Market Size
2.1 Global Highly Active Antiretroviral Therapy (HAART) Market Size: 2022 VS 2029
2.2 Global Highly Active Antiretroviral Therapy (HAART) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Highly Active Antiretroviral Therapy (HAART) Players in Global Market
3.2 Top Global Highly Active Antiretroviral Therapy (HAART) Companies Ranked by Revenue
3.3 Global Highly Active Antiretroviral Therapy (HAART) Revenue by Companies
3.4 Top 3 and Top 5 Highly Active Antiretroviral Therapy (HAART) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Highly Active Antiretroviral Therapy (HAART) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Highly Active Antiretroviral Therapy (HAART) Players in Global Market
3.6.1 List of Global Tier 1 Highly Active Antiretroviral Therapy (HAART) Companies
3.6.2 List of Global Tier 2 and Tier 3 Highly Active Antiretroviral Therapy (HAART) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Highly Active Antiretroviral Therapy (HAART) Market Size Markets, 2022 & 2029
4.1.2 Nucleoside Reverse Transcriptase Inhibitors (NRTI)
4.1.3 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
4.1.4 Protease Inhibitor (PI)
4.2 By Type - Global Highly Active Antiretroviral Therapy (HAART) Revenue & Forecasts
4.2.1 By Type - Global Highly Active Antiretroviral Therapy (HAART) Revenue, 2018-2023
4.2.2 By Type - Global Highly Active Antiretroviral Therapy (HAART) Revenue, 2024-2029
4.2.3 By Type - Global Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Highly Active Antiretroviral Therapy (HAART) Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Highly Active Antiretroviral Therapy (HAART) Revenue & Forecasts
5.2.1 By Application - Global Highly Active Antiretroviral Therapy (HAART) Revenue, 2018-2023
5.2.2 By Application - Global Highly Active Antiretroviral Therapy (HAART) Revenue, 2024-2029
5.2.3 By Application - Global Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Highly Active Antiretroviral Therapy (HAART) Market Size, 2022 & 2029
6.2 By Region - Global Highly Active Antiretroviral Therapy (HAART) Revenue & Forecasts
6.2.1 By Region - Global Highly Active Antiretroviral Therapy (HAART) Revenue, 2018-2023
6.2.2 By Region - Global Highly Active Antiretroviral Therapy (HAART) Revenue, 2024-2029
6.2.3 By Region - Global Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Highly Active Antiretroviral Therapy (HAART) Revenue, 2018-2029
6.3.2 US Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.3.3 Canada Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.3.4 Mexico Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Highly Active Antiretroviral Therapy (HAART) Revenue, 2018-2029
6.4.2 Germany Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.4.3 France Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.4.4 U.K. Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.4.5 Italy Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.4.6 Russia Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.4.7 Nordic Countries Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.4.8 Benelux Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Highly Active Antiretroviral Therapy (HAART) Revenue, 2018-2029
6.5.2 China Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.5.3 Japan Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.5.4 South Korea Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.5.5 Southeast Asia Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.5.6 India Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Highly Active Antiretroviral Therapy (HAART) Revenue, 2018-2029
6.6.2 Brazil Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.6.3 Argentina Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Highly Active Antiretroviral Therapy (HAART) Revenue, 2018-2029
6.7.2 Turkey Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.7.3 Israel Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.7.4 Saudi Arabia Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
6.7.5 UAE Highly Active Antiretroviral Therapy (HAART) Market Size, 2018-2029
7 Highly Active Antiretroviral Therapy (HAART) Companies Profiles
7.1 Gilead
7.1.1 Gilead Company Summary
7.1.2 Gilead Business Overview
7.1.3 Gilead Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.1.4 Gilead Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.1.5 Gilead Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.2.4 Roche Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 ViiV Healthcare
7.3.1 ViiV Healthcare Company Summary
7.3.2 ViiV Healthcare Business Overview
7.3.3 ViiV Healthcare Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.3.4 ViiV Healthcare Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.3.5 ViiV Healthcare Key News & Latest Developments
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.4.4 Boehringer Ingelheim Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.4.5 Boehringer Ingelheim Key News & Latest Developments
7.5 Johnson and Johnson
7.5.1 Johnson and Johnson Company Summary
7.5.2 Johnson and Johnson Business Overview
7.5.3 Johnson and Johnson Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.5.4 Johnson and Johnson Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.5.5 Johnson and Johnson Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.6.4 Mylan Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.6.5 Mylan Key News & Latest Developments
7.7 Bionor Pharma
7.7.1 Bionor Pharma Company Summary
7.7.2 Bionor Pharma Business Overview
7.7.3 Bionor Pharma Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.7.4 Bionor Pharma Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.7.5 Bionor Pharma Key News & Latest Developments
7.8 Vertex Pharmaceuticals
7.8.1 Vertex Pharmaceuticals Company Summary
7.8.2 Vertex Pharmaceuticals Business Overview
7.8.3 Vertex Pharmaceuticals Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.8.4 Vertex Pharmaceuticals Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.8.5 Vertex Pharmaceuticals Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.9.4 Merck Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.9.5 Merck Key News & Latest Developments
7.10 CIPLA
7.10.1 CIPLA Company Summary
7.10.2 CIPLA Business Overview
7.10.3 CIPLA Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.10.4 CIPLA Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.10.5 CIPLA Key News & Latest Developments
7.11 AbbVie
7.11.1 AbbVie Company Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Highly Active Antiretroviral Therapy (HAART) Major Product Offerings
7.11.4 AbbVie Highly Active Antiretroviral Therapy (HAART) Revenue in Global Market (2018-2023)
7.11.5 AbbVie Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Highly Active Antiretroviral Therapy (HAART) Market Opportunities & Trends in Global Market
Table 2. Highly Active Antiretroviral Therapy (HAART) Market Drivers in Global Market
Table 3. Highly Active Antiretroviral Therapy (HAART) Market Restraints in Global Market
Table 4. Key Players of Highly Active Antiretroviral Therapy (HAART) in Global Market
Table 5. Top Highly Active Antiretroviral Therapy (HAART) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Highly Active Antiretroviral Therapy (HAART) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Highly Active Antiretroviral Therapy (HAART) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Highly Active Antiretroviral Therapy (HAART) Product Type
Table 9. List of Global Tier 1 Highly Active Antiretroviral Therapy (HAART) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Highly Active Antiretroviral Therapy (HAART) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Highly Active Antiretroviral Therapy (HAART) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Highly Active Antiretroviral Therapy (HAART) Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Highly Active Antiretroviral Therapy (HAART) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Highly Active Antiretroviral Therapy (HAART) Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2024-2029
Table 30. Gilead Company Summary
Table 31. Gilead Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 32. Gilead Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 36. Roche Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. ViiV Healthcare Company Summary
Table 39. ViiV Healthcare Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 40. ViiV Healthcare Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 41. ViiV Healthcare Key News & Latest Developments
Table 42. Boehringer Ingelheim Company Summary
Table 43. Boehringer Ingelheim Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 44. Boehringer Ingelheim Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 45. Boehringer Ingelheim Key News & Latest Developments
Table 46. Johnson and Johnson Company Summary
Table 47. Johnson and Johnson Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 48. Johnson and Johnson Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson and Johnson Key News & Latest Developments
Table 50. Mylan Company Summary
Table 51. Mylan Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 52. Mylan Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 53. Mylan Key News & Latest Developments
Table 54. Bionor Pharma Company Summary
Table 55. Bionor Pharma Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 56. Bionor Pharma Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 57. Bionor Pharma Key News & Latest Developments
Table 58. Vertex Pharmaceuticals Company Summary
Table 59. Vertex Pharmaceuticals Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 60. Vertex Pharmaceuticals Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 61. Vertex Pharmaceuticals Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 64. Merck Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. CIPLA Company Summary
Table 67. CIPLA Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 68. CIPLA Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 69. CIPLA Key News & Latest Developments
Table 70. AbbVie Company Summary
Table 71. AbbVie Highly Active Antiretroviral Therapy (HAART) Product Offerings
Table 72. AbbVie Highly Active Antiretroviral Therapy (HAART) Revenue (US$, Mn) & (2018-2023)
Table 73. AbbVie Key News & Latest Developments
List of Figures
Figure 1. Highly Active Antiretroviral Therapy (HAART) Segment by Type in 2022
Figure 2. Highly Active Antiretroviral Therapy (HAART) Segment by Application in 2022
Figure 3. Global Highly Active Antiretroviral Therapy (HAART) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Highly Active Antiretroviral Therapy (HAART) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Highly Active Antiretroviral Therapy (HAART) Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Highly Active Antiretroviral Therapy (HAART) Revenue in 2022
Figure 8. By Type - Global Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
Figure 9. By Application - Global Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
Figure 10. By Type - Global Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
Figure 12. By Application - Global Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
Figure 14. By Region - Global Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
Figure 15. By Country - North America Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
Figure 16. US Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
Figure 20. Germany Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 21. France Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
Figure 28. China Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 32. India Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
Figure 34. Brazil Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Highly Active Antiretroviral Therapy (HAART) Revenue Market Share, 2018-2029
Figure 37. Turkey Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Highly Active Antiretroviral Therapy (HAART) Revenue, (US$, Mn), 2018-2029
Figure 41. Gilead Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. ViiV Healthcare Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Boehringer Ingelheim Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson and Johnson Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Mylan Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bionor Pharma Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Vertex Pharmaceuticals Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merck Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CIPLA Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. AbbVie Highly Active Antiretroviral Therapy (HAART) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
